List of Protonix Iv drug patents

Protonix Iv is owned by Wyeth Pharms.

Protonix Iv contains Pantoprazole Sodium.

Protonix Iv has a total of 3 drug patents out of which 3 drug patents have expired.

Expired drug patents of Protonix Iv are:

  • US6780881*PED
  • US7351723*PED
  • US8754108*PED

Protonix Iv was authorised for market use on 22 March, 2001.

Protonix Iv is available in injectable;intravenous dosage forms.

The generics of Protonix Iv are possible to be released after 17 May, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6780881

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(1 year, 12 days ago)

US7351723

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(1 year, 12 days ago)

US8754108

(Pediatric)

WYETH PHARMS Freeze-dried pantoprazole preparation and pantoprazole injection
May, 2022

(1 year, 12 days ago)

Do you want to check out PROTONIX IV patents from before 2022?

Drugs and Companies using PANTOPRAZOLE SODIUM ingredient

Market Authorisation Date: 22 March, 2001

Treatment: NA

Dosage: INJECTABLE;INTRAVENOUS

How can I launch a generic of PROTONIX IV before it's patent expiration?
More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in